Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism

Hypoxia-inducible factor (HIF) prolyl 4-hydroxylases (HIF-P4Hs 1–3) are druggable targets in renal anemia, where pan-HIF-P4H inhibitors induce an erythropoietic response. Preclinical data suggest that HIF-P4Hs could also be therapeutic targets for treating metabolic dysfunction, although the contrib...

Descripción completa

Detalles Bibliográficos
Autores principales: Tapio, Joona, Halmetoja, Riikka, Dimova, Elitsa Y., Mäki, Joni M., Laitala, Anu, Walkinshaw, Gail, Myllyharju, Johanna, Serpi, Raisa, Koivunen, Peppi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352911/
https://www.ncbi.nlm.nih.gov/pubmed/35787374
http://dx.doi.org/10.1016/j.jbc.2022.102222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352911/
https://www.ncbi.nlm.nih.gov/pubmed/35787374
http://dx.doi.org/10.1016/j.jbc.2022.102222

Ejemplares similares